Compared to the placebo treatment, kisspeptin led to a 48-fold increase in LH and 16-fold increase in FSH.
与安慰剂相比,kisspeptin引起LH激素增长48倍,FSH激素增长16倍。
Most patients also received a placebo treatment during the study, an injection of saline solution, and showed no improvement.
大多数患者在研究过程在中同时还接受了安慰剂治疗,即一种盐溶剂注射剂,但没有什么效果。
Hirudoid has been proven to significantly improve the metabolic situation in the early pressure areas when compared to placebo treatment.
经论证,对于早期受压区域代谢的改善,喜疗妥组显著优于安慰剂组。
应用推荐